NJ S 322
withdrawnEstablishes tianeptine as Schedule II controlled dangerous substance.
New Jersey · 222 · upper
Quick answers
Did NJ S 322 pass?
No. NJ S 322 was withdrawn on 2026-01-13 and is no longer under consideration. Latest recorded action (2026-01-13): Withdrawn Because Approved P.L.2025, c.249.
What is NJ S 322 about?
NJ S 322 is a bill in the 222 titled “Establishes tianeptine as Schedule II controlled dangerous substance.”.
Who sponsors NJ S 322?
Steinhardt, Douglas J., Singleton, Troy are the primary sponsors of NJ S 322, joined by 1 cosponsor.
- Introduced
- 2026-01-13
- Latest action
- 2026-01-13 — Withdrawn Because Approved P.L.2025, c.249.
- Bill type
- bill
- Last updated
- —
Sponsors
- Steinhardt, Douglas J.primary
- Singleton, Troyprimary
- Moriarty, Paul D.cosponsor
Committees
Not provided by source.
Action timeline
2026-01-13
Introduced in the Senate, Referred to Senate Judiciary Committee
introduction,referral-committee
2026-01-13
Withdrawn Because Approved P.L.2025, c.249.
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:43.923511Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=S 322. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.